Inhibitors | Comment | Organism | Structure |
---|---|---|---|
N2-(3-(trifluoromethyl)benzyl)-N6-(4-nitrobenzyl)purine | - |
Danio rerio |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Danio rerio | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
embryo | - |
Danio rerio | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 1D-myo-inositol hexakisphosphate | - |
Danio rerio | ADP + 5-diphospho-1D-myo-inositol (1,2,3,4,6)-pentakisphosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
inositol hexakisphosphate kinase-2 | - |
Danio rerio |
IP6K2 | - |
Danio rerio |
General Information | Comment | Organism |
---|---|---|
malfunction | isoform IP6K2 depletion inhibits Hh target gene expression. Inhibiting enzyme activity results in altered Hedgehog signal transduction. Isoform IP6K2 knockdown alters craniofacial and somite structures and inhibits the development and migration of neural crest cells | Danio rerio |
metabolism | isoform inositol hexakisphosphate kinase-2 acts as an effector of the vertebrate Hedgehog pathway. IP6K2 activity is required at the level or downstream of Smoothened but upstream of the transcription activator Gli1 | Danio rerio |
physiological function | isoform P6K2 activity is required for normal development of craniofacial structures, somites, and neural crest cells | Danio rerio |